Live Breaking News & Updates on Steven Lichtman Oppenheimer Company Analyst

Stay updated with breaking news from Steven lichtman oppenheimer company analyst. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Integra Lifesciences Holdings Corp (IART) Q1 2021 Earnings Call Transcript

Integra Lifesciences Holdings Corp (IART) Q1 2021 Earnings Call Transcript
Motley Fool Transcribers
© The Motley Fool
Logo of jester cap with thought bubble.
Integra Lifesciences Holdings Corp (NASDAQ: IART)
Popular Searches
Operator
Ladies and gentlemen, good day, and welcome to the Integra LifeSciences First Quarter 2021 Financial Results Call. At this time, I would like to turn the conference over to Mr. Mike Beaulieu, Head of Investor Relations. Please go ahead, sir.SPONSORED:
10 stocks we like better than Integra LifeSciences
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, ....

United States , New Zealand , United Kingdom , Xu Yang , Integra Lifesciences , Matt Obrien , Dave Turkaly , Raymond James , Jayson Bedford , Mike Mcbrain , Shagun Singh , Robbie Marcus , Anthony Petrone Jefferies , Aurora Surgiscope , Asia Pacific , Korinne Wolfmeyer Piper Sandler , Kaila Krum Truist , Jayson Bedford Raymond James , Matt Taylor , Piper Sandler , Robbie Marcus Jpmorgan , Steven Lichtman , Carrie Anderson , Matt Miksic , Mike Beaulieu , Glenn Coleman ,

Organogenesis Holdings Inc (ORGO) Q4 2020 Earnings Call Transcript

Operator
Good afternoon, ladies and gentlemen, and welcome to the fourth-quarter 2020 earnings conference call for Organogenesis Holdings, Inc. [Operator instructions] Please note that this conference call is being recorded and that the recording will be available on the company s website for replay shortly. Before we begin, I would like to remind everyone that our remarks today may contain forward-looking statements that are based on the current expectations of management and involve inherent risks and uncertainties that could cause actual results to differ materially from those indicated, including the risks and uncertainties described in the company s filings with the Securities and Exchange Commission, including Item 1A, Risk Factors, of the company s most recent annual and quarterly reports. You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date today. ....

Richard Newitter , Steven Lichtman , Dave Francisco , Matt Miksic , Gary Gillheeney , David Francisco , Ryan Zimmerman , Exchange Commission , Organogenesis Holdings Inc , Organogenesis Holdings , Organogenesis Holding , Steven Lichtman Oppenheimer Company Analyst , Credit Suisse , Risk Factors , Investor Relations , Chief Executive , Advanced Wound Care , Sports Medicine , Renu Regenerative Medicine Advanced Therapy , ஸ்டீவன் லிட்ச்மேன் , டேவ் பிரான்சிஸ்கோ , டேவிட் பிரான்சிஸ்கோ , ரியான் ஸிம்மர்மந் , பரிமாற்றம் தரகு , ஸ்டீவன் லிட்ச்மேன் ஆபெந்ஹைமர் நிறுவனம் ஆய்வாளர் , கடன் ஸ்யூயி ,

Glaukos Corp (GKOS) Q4 2020 Earnings Call Transcript

Operator
Welcome to Glaukos Corporation s Fourth Quarter and Full Year 2020 Financial Results Conference Call. A copy of the company s press release issued after the market close today is available at www.glaukos.com. [Operator Instructions] This call is being recorded and archived replay will be available online in the Investor Relations section at www.glaukos.com.
I will now turn the call over to Chris Lewis, Director of Investor Relations and Corporate Strategy and Development.
Chris Lewis
Director of Investor Relations and Corporate Strategy and Development
Thank you, and good afternoon. Joining me today are Glaukos President and CEO, Tom Burns; CFO, Joe Gilliam; and COO, Chris Calcaterra. [Operator Instructions] Please note that all statements other than statements of historical facts made on this call that address activities, events or developments we expect, believe, or anticipate, will or may occur in the future are forward-looking statements. These ....

United States , Chris Calcaterra , Chris Lewis , Andrew Brackmann William Blair , Andrew Brackmann , Robbie Marcus , Ravi Masri , Anthony Petrone Jefferies , Chris Cooley Stephens , Matt Obrien Piper Sandler , Andrew Stafford Piper Sandler , Thomasw Burns , Josephe Gilliam , Ravi Masri Berenberg , Joe Gilliam , Chris Cooley , Tom Burns , Steven Lichtman , K Gong Jpmorgan , William Blair , Anthony Petrone , Glaukos Corp , Steven Lichtman Oppenheimer Company Analyst , Corneal Health , Glaukos Corporation , Corporate Development ,